KND Naval Design of Cape Town, South Africa successfully completed its first in class 10M Advanced Life Support Ambulance and Rescue vessel for Africa. This project used HydroComp SwiftTrial software. Naval architect Kobus Potgieter ...
Tags: HydroComp Software, Software, Ambulance Vessel, Computer Products
Lexicon Pharmaceuticals has won Fast Track status from the US FDA to develop LX1033, an orally-delivered small molecule drug candidate to treat diarrhea-predominant irritable bowel syndrome (IBS-d). Fast Track facilitates the development ...
Tags: Lexicon Pharmaceuticals, small molecule drug candidate
The US Court of Appeals for the Federal Circuit has confirmed a prior ruling by the US District Court for the District of Delaware that the Eli Lilly and Company's compound patent for Alimta (pemetrexed) is valid. The compound patent ...
SPI subsidiary Sucampo Pharmaceuticals has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a prescription drug for the treatment of chronic constipation, excluding constipation caused by ...
Tags: amitiza, lubiprostone, treatment of chronic constipation, prostone
The US Food and Drug Administration (FDA) has granted fast track designation to Alvine Pharmaceuticals' ALV003 for the potential treatment of celiac disease. Alvine is at present conducting Phase 2 trials with ALV003, an orally ...
Tags: ALV003, treatment of celiac disease, orally administered mixture
Janssen-Cilag International has submitted a Marketing Authorisation Application to the European Medicines Agency (EMA) seeking conditional approval to use the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as ...
Tags: investigational drug bedaquiline, multi-drug resistant tuberculosis
BG Medicine has announced the availability of galectin-3 testing services through Atherotech Diagnostics Lab. Atherotech leverages BGM Galectin-3 test to offer galectin-3 testing. The BGM Galectin-3 test was cleared as an aid in ...
Janssen Research & Development company has submitted bedaquiline (TMC207) new drug application (NDA) to the US Food and Drug Administration (FDA) for approval. Bedaquiline,an investigational drug administered orally,is used as part of ...
Tags: FDA, new drug application, investigational drug, pulmonary
BioFocus, the Galapagos' service division, and Ono Pharmaceutical have signed a new drug discovery agreement focusing on CNS disorders. BioFocus managing director and Galapagos Services SVP Dr. Chris Newton said, "This project plays to ...
Theravance has entered into a research partnership with Merck, known as MSD outside the US and Canada, for the development of potential cardiovascular therapeutics to treat hypertension and heart failure. As per the agreement, Merck will ...
Tags: Cardiovascular Therapeutics, Theravance, Merck, MSD
Synthetic Biologics has enterd into second worldwide exclusive channel collaboration with Intrexon to address unmet medical needs of infectious diseases. Synthetic Biologics leverages Intrexon's suite of proprietary technologies for the ...
Tags: Synthetic Biologics, infectious diseases, medical needs
Brainsway has started the multicenter clinical trial of its Deep TMS device, designed to treat various neurological and psychopathological disorders. Noninvasive Deep TMS device has also the potential to treat schizophrenia, obesity, ...
Tags: Brainsway, Deep TMS device, Parkinson's disease, Alzheimer's disease
The US Food and Drug Administration (FDA) has approved Pfizer's Lyrica (pregabalin) capsules CV for the management of neuropathic pain associated with spinal cord injury based on priority review. The FDA approval is based on two ...
Tags: FDA approval, neuropathic pain, Lyrica, clinical researh
The US Food and Drug Administration (FDA) has cleared Arteriocyte Medical Systems' 50cc volume of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation system. The Magellan system utilizes ...
Tags: FDA, Anticoagulant Citrate Dextrose Solution, clinical technology
Biocon has invested in new integrated research and development centre, Biocon Research Center (BRC), in South-East Asia to conduct research on biologics that will deal with unmet medical needs. The 200,000ft2 will accommodate the ...
Tags: Biocon, invested, BRC, research on biologics, South-East Asia